TABLE 1. Percentage of splenocytes expressing surface antigenic markers in each group.
Data are means ± S.D. (% (gated)), n = 8. CS was administered orally ad libitum from 7 days before the first immunization to 7 days after the second immunization. The control group had ad libitum free access to water.
| CD3+CD45R/B220−, T cell | CD3−CD45R/B220+, B cell | CD4+CD8−, CD4 | CD4−CD8+, CD8 | CD4+CD25+ | |
|---|---|---|---|---|---|
| CS | 38.0 ± 2.8 | 52.9 ± 2.0 | 27.7 ± 2.0a | 11.8 ± 0.7a | 4.4 ± 0.5b |
| Control | 36.2 ± 2.8 | 53.2 ± 2.6 | 25.2 ± 1.3 | 10.8 ± 0.9 | 3.9 ± 0.3 |
a
Significantly different from control at p < 0.05.
b
Significantly different from control at p < 0.01.